Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Skandia in connection with its investment in Lumera
Mandate

Vinge advises Skandia in connection with its investment in Lumera

June 27, 2023 Banking and Finance M&A

Vinge has advised Skandia in connection with its acquisition of a minority stake in Lumera from Monterro.

In connection therewith AMF is also acquiring a minority stake from Monterro, and Monterro is reinvesting in Lumera through its M4 fund, which means that Monterro remains the majority shareholder through its M2 and M4 funds. Lumera is a software company that develops business systems for the life and pension insurance industry, including a cloud-based system that administers insurance policies.

Vinge's team consisted of Viveka Classon, Samra Tesser, Jonna Bondemark and Philip Moré.

 

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

 Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

 Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025